exhibition
register now
get brochure
add event to diary
email this to...
contact us
Contact LIVE

look back at 2008
  • 100+ participants
  • 8 health agency speakers
  • 21 sessions over 3 days
  • 65% industry participation
  • 28 hours total duration
  • 7 hours networking time
  • › Request 2009 brochure

    conference details
    Conference:
    Pre-conference workshop
    8 December 9am - 5pm
    Day 1
    9 December 8am - 5.30pm
    Day 2
    10 December 8am - 5.30pm
    Post-conference workshop
    11 December 9am - 5pm
     
    Venue: Royal Garden Hotel, London, United Kingdom
     
     
    Register online now 
    or call +44 (0) 207 608 7055

     

     

     

    Julie Ann Bridge,
    Head of Health Technology Assessment Policy and Development and Account Management
    Pfizer, Inc.

    A health economist who has worked and studied in Australia, USA and UK, Julie Ann has worked with Pfizer for the past ten years, initially within Outcomes Research leading a team developing programs and submissions for new product development and established medicines. More recently Julie Ann has taken the lead in HTA policy.
    Appearing:
    Day Two - Thursday 10 December 2009
    11.30am

    The innovation debate

    • Is there any more to be said?
    • How critical is path dependency in medicines?
    • Is there a market failure to be addressed?
    • The challenge of maintaining the incentives to produce new medicines
    Head of Health Technology Assessment Policy and Development and Account Management,
    Pfizer, Inc.

    Sponsors
     

     
    our speakers
    Meindert Boysen
    Associate Director Single Technology Appraisals
    NICE
     
    Dr François Meyer
    Director, Health Technology Assessment Division
    Haute Autorité de
    Santé
     
    Dr Allan Korn
    Senior Vice President, Chief Medical Officer
    BlueCross BlueShield Association
     
    Jerome Boehm
    Head EU level activities on HTA
    European Commission
     
    Dr Matthias Perleth
    Head of Methods Department
    Gemeinsamer Bundesausschuss

     

    comment / report a mistake | contact us | about Terrapinn | site map | privacy | T&Cs a terrapin ©Terrapinn Holdings Ltd. MMX